Addition of long‐acting beta‐agonists to inhaled corticosteroids for asthma in preschool children: A systematic review
dc.catalogador | vzp | |
dc.contributor.author | Ambrozej, Dominika | |
dc.contributor.author | Cieslik, Cieslik | |
dc.contributor.author | Feleszko, Wojciech | |
dc.contributor.author | Rodriguez-Martinez, Carlos E. | |
dc.contributor.author | Castro Rodríguez, José Antonio | |
dc.date.accessioned | 2025-03-12T13:26:49Z | |
dc.date.available | 2025-03-12T13:26:49Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) are essential in asthma management, but the guidelines for treatment in preschool children remain heterogeneous worldwide. This systematic review evaluates the efficacy and safety of LABA + ICS therapy in asthmatic children under six years. We searched four databases, identifying six eligible studies (n = 1415 preschoolers), and in all the LABA used was salmeterol. Due to high heterogeneity, quantitative analysis was not feasible. Three before-and-after studies demonstrated significant reductions in unscheduled visits and hospitalizations due to asthma exacerbations with LABA + ICS. One RCT showed fewer exacerbations in the LABA + ICS group compared to ICS alone. Night-time awakenings decreased significantly in two studies but not in one RCT. Improvements in lung function using impulse oscillometry and FeNO levels were noted with LABA+ICS in one RCT. No significant adverse effects were reported. Despite positive findings, high-quality trials are needed to confirm these results, particularly using formoterol as LABA, aligning with the recommendations. Further research is imperative to optimize asthma management in preschool children. | |
dc.format.extent | 7 páginas | |
dc.fuente.origen | SCOPUS | |
dc.identifier.doi | 10.1016/j.prrv.2024.09.002 | |
dc.identifier.issn | 15260550 15260542 | |
dc.identifier.issn | 1526-0542 | |
dc.identifier.scopusid | SCOPUS_ID:85208386117 | |
dc.identifier.uri | https://doi.org/10.1016/j.prrv.2024.09.002 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/102508 | |
dc.information.autoruc | Escuela de Medicina; Castro Rodríguez, José Antonio; 0000-0002-0708-4281; 113247 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.publisher | W.B. Saunders Ltd | |
dc.revista | Paediatric Respiratory Reviews | |
dc.rights | acceso restringido | |
dc.subject | Asthma | |
dc.subject | Child | |
dc.subject | ICS | |
dc.subject | LABA | |
dc.subject | Preschool | |
dc.subject | Systematic review | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.ods | 03 Good health and well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Addition of long‐acting beta‐agonists to inhaled corticosteroids for asthma in preschool children: A systematic review | |
dc.type | artículo | |
sipa.codpersvinculados | 113247 | |
sipa.trazabilidad | SCOPUS;2024-11-17 |